Cagrilintide
Long-Acting Acylated Amylin Analogue — AMY Receptor / Calcitonin Receptor Agonist (NN9838)
Cagrilintide (NN9838) is a long-acting synthetic amylin analogue incorporating Pro substitutions at positions 25, 28, and 29 to impede β-sheet fibril formation, a 14E/17R salt-bridge stabilising the central α-helix, and a C20 fatty diacid N-terminal lipid for albumin-mediated extended half-life (~7–8 days). It acts as a non-selective agonist at AMY1R, AMY2R, AMY3R, and CTR, activating adenylyl cyclase and cAMP-mediated signalling. Research has characterised cagrilintide in hypothalamic appetite-regulatory circuits, area postrema satiety pathways, and combinatorial metabolic endpoints in co-administration study designs.
| PROPERTIES | |
|---|---|
| Molecular Formula | C194H312N54O59S2 |
| Molecular Weight (g/mol) | 4409 |
| Monoisotopic Mass (Da) | 4406.2515 |
| Topological Polar Surface Area (Ų) | 1880 |
| Complexity | 10800 |
| XLogP (octanol-water partition) | -12.5 |
| Heavy Atom Count | 309 |
| H-Bond Donor Count | 60 |
| H-Bond Acceptor Count | 65 |
| Rotatable Bond Count | 137 |
| InChIKey | LDERDVMBIYGIOI-IZVMHKDJSA-N |
| PubChem CID | 171397054 |
All values above are taken from PubChem CID 171397054 and can be checked against that record.
2D Structure
| CHEMICAL IDENTIFIERS | |
|---|---|
| CAS Number | 1415456-99-3 |
| PubChem CID | 171397054 |
| IUPAC Name | 20-[[(1S)-4-[[(2S)-6-amino-1-[[(4R,7S,10S,13S,16S,19R)-4-[[(2S)-1-[[(2S,3R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[(2S)-2-[[(2S,3S)-1-[[(2R)-1-[(2R)-2-[(2R)-2-[[(2R,3S)-1-[[(2R)-4-amino-1-[[(2R)-1-[[2-[[(2R)-1-[[(2R)-4-amino-1-[[(2R,3S)-1-[(2R)-2-carbamoylpyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]-16-(2-amino-2-oxoethyl)-7,13-bis[(1R)-1-hydroxyethyl]-10-methyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxohexan-2-yl]amino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid |
| InChIKey | LDERDVMBIYGIOI-IZVMHKDJSA-N |
| InChI | InChI=1S/C194H312N54O59S2/c1-19-100(10)151(184(298)233-128(78-98(6)7)189(303)248-75-49-60-137(248)190(304)247-74-48-59-136(247)182(296)243-155(107(17)255)187(301)232-127(86-143(201)262)173(287)238-150(99(8)9)183(297)210-88-146(265)218-129(90-249)176(290)230-126(85-142(200)261)175(289)244-156(108(18)256)191(305)246-73-46-57-134(246)157(202)271)239-181(295)135-58-47-72-245(135)147(266)89-211-161(275)120(79-109-50-36-34-37-51-109)225-171(285)123(82-139(197)258)228-172(286)124(83-140(198)259)229-177(291)130(91-250)235-178(292)131(92-251)234-170(284)122(81-111-87-207-95-212-111)227-164(278)114(56-45-71-209-194(205)206)221-168(282)119(77-97(4)5)224-169(283)121(80-110-52-38-35-39-53-110)226-166(280)116(65-68-149(269)270)219-158(272)101(11)213-167(281)118(76-96(2)3)223-163(277)113(55-44-70-208-193(203)204)220-165(279)115(63-66-138(196)257)222-186(300)153(105(15)253)240-159(273)102(12)214-179(293)132-93-308-309-94-133(180(294)231-125(84-141(199)260)174(288)242-152(104(14)252)185(299)215-103(13)160(274)241-154(106(16)254)188(302)237-132)236-162(276)112(54-42-43-69-195)216-145(264)67-64-117(192(306)307)217-144(263)61-40-32-30-28-26-24-22-20-21-23-25-27-29-31-33-41-62-148(267)268/h34-39,50-53,87,95-108,112-137,150-156,249-256H,19-33,40-49,54-86,88-94,195H2,1-18H3,(H2,196,257)(H2,197,258)(H2,198,259)(H2,199,260)(H2,200,261)(H2,201,262)(H2,202,271)(H,207,212)(H,210,297)(H,211,275)(H,213,281)(H,214,293)(H,215,299)(H,216,264)(H,217,263)(H,218,265)(H,219,272)(H,220,279)(H,221,282)(H,222,300)(H,223,277)(H,224,283)(H,225,285)(H,226,280)(H,227,278)(H,228,286)(H,229,291)(H,230,290)(H,231,294)(H,232,301)(H,233,298)(H,234,284)(H,235,292)(H,236,276)(H,237,302)(H,238,287)(H,239,295)(H,240,273)(H,241,274)(H,242,288)(H,243,296)(H,244,289)(H,267,268)(H,269,270)(H,306,307)(H4,203,204,208)(H4,205,206,209)/t100-,101+,102-,103-,104+,105+,106+,107-,108-,112-,113-,114-,115-,116-,117-,118+,119-,120-,121-,122-,123-,124-,125-,126+,127+,128+,129+,130-,131-,132-,133-,134+,135-,136+,137+,150+,151-,152-,153-,154-,155+,156+/m0/s1 |
| SMILES | CC[C@H](C)[C@@H](C(=O)N[C@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)N2CCC[C@@H]2C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](C(C)C)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H]([C@H](C)O)C(=O)N3CCC[C@@H]3C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@@H]8CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8)[C@@H](C)O)C)[C@@H](C)O)CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O |
Identifiers retrieved from PubChem CID 171397054.
Certificate of analysis Sample lot
Cagrilintide
- Lot
- DL26082102
- SKU
- GD-CAGR
- Manufactured
- 21 Aug 2026
- Retest
- 21 Aug 2028
Reported composition each test reported separately, not a mass balance
Every figure is the result printed on the certificate. Purity is by HPLC area integration and the others are separate determinations on the same lot, so they are shown as separate bars rather than as shares of one total.
Test results as reported
| # | Test | Specification | Result |
|---|---|---|---|
| 1 | Appearance | White or almost white powder | Conforms |
| 2 | Related substances: total impurities | ≤1.0% | 0.77% |
| 3 | Related substances: maximum single impurity | ≤0.5% | 0.34% |
| 4 | Identification by MS | 4409.07 ± 4 | Conforms |
| 5 | Water content (Karl Fischer) | ≤8.0% | 4.83% |
| 6 | Peptide purity (by HPLC) | ≥99.0% | 99.23% |
| 7 | Peptide content | ≥80.0% | 88.33% |
| 8 | Solubility | Soluble in water | Conforms |
| 9 | Bacterial endotoxins | ≤10 EU/mg | Conforms |
| 10 | Residual solvent: methylene chloride | ≤600 ppm | N.D |
| 11 | Residual solvent: acetonitrile | ≤410 ppm | 122 ppm |
| 12 | Residual solvent: methanol | ≤3000 ppm | N.D |
| 13 | Residual solvent: N,N-dimethylformamide | ≤880 ppm | N.D |
| 14 | Counter-ion: trifluoroacetate | ≤1000 ppm | N.D |
| 15 | Counter-ion: phosphate | ≤1000 ppm | N.D |
| 16 | Counter-ion: chloride | ≤1000 ppm | N.D |
| 17 | Counter-ion: acetic acid | ≤8.0% | 6.51% |
| 18 | Escherichia coli | Not detected | Conforms |
| 19 | Pseudomonas aeruginosa | Not detected | Conforms |
| 20 | Salmonella | Not detected | Conforms |
| 21 | Microbial limits: TAMC | ≤1000 cfu/g | Conforms |
| 22 | Microbial limits: TYMC | ≤100 cfu/g | Conforms |
Identity verified against PubChem, not a measurement of this lot
- CAS number
- 1415456-99-3
- Molecular formula
- C194H312N54O59S2
- Molecular weight
- 4409.0 g/mol
- Monoisotopic mass
- 4406.2515 Da
- InChIKey
- LDERDVMBIYGIOI-IZVMHKDJSA-N
- PubChem CID
- 171397054
Corrections and queries 1 corrected, 1 queried with the supplier
| Field | On the supplier document | Here | Why |
|---|---|---|---|
| Microbial test name | Escherichia Coil | Escherichia coli | Spelling. |
| Identity by MS | Conforms, with no observed mass | shown as reported, queried | The report gives the target 4409.07 +/- 4 and the word Conforms, but no measured mass. We have asked for the observed value. |
A measured result is never rewritten. Where a reported figure does not stand up, it is shown as printed and marked as queried.
Sample lot. This is the report supplied with the sample of this compound. A production lot ships with its own report, published here in the same form and indexed by its own lot number.
Every analytical figure above is transcribed from the supplier’s report for lot DL26082102. Identity is the PubChem record, which can be checked independently. Purity is the main peak’s share of integrated peak area at the detection wavelength, so it measures related impurities. Water, salts and counter-ions are not part of it. These are the supplier’s release documents, not independent third-party tests.
This product is sold exclusively for in vitro and laboratory research use. It has not been evaluated by the FDA. Not approved for diagnostic, therapeutic, or veterinary use.
PT-141
Tirzepatide
NAD+
KPV